Stay updated on Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Release v3.0.2 adds Oren C Pasvolsky, MD and new date markers, updates the 'Last Update Posted' label to '(Estimated)', and removes the previous contributor and a minor UI item; reflects a versioned content/credit refresh.
    Difference
    0.9%
    Check dated 2025-09-14T19:16:18.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T15:37:15.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms and compounds related to plasma cell myeloma treatment. Notably, daratumumab and ixazomib are mentioned, while several previous terms related to multiple myeloma and various drug classifications have been removed.
    Difference
    5%
    Check dated 2025-08-31T11:58:01.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:32:33.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:26:32.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-01T18:49:04.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page.